1. Home
  2. ADIG vs GHRS Comparison

ADIG vs GHRS Comparison

Compare ADIG & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADI Global Distribution Inc. Common Stock

ADIG

ADI Global Distribution Inc. Common Stock

N/A

Current Price

$18.57

Market Cap

1.7B

Sector

Industrials

ML Signal

N/A

Logo GH Research PLC

GHRS

GH Research PLC

N/A

Current Price

$20.54

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ADIG
GHRS
Founded
1929
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
ADIG
GHRS
Price
$18.57
$20.54
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$26.40
★ $42.89
AVG Volume (30 Days)
★ 451.9K
303.8K
Earning Date
08-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.99
N/A
Revenue Next Year
$4.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.00
$12.04
52 Week High
$30.99
$31.44

Technical Indicators

Market Signals
Indicator
ADIG
GHRS
Relative Strength Index (RSI) 57.01 47.24
Support Level N/A $19.75
Resistance Level $22.31 $22.88
Average True Range (ATR) 0.97 1.13
MACD 0.43 0.54
Stochastic Oscillator 96.61 69.72

Price Performance

Historical Comparison
ADIG
GHRS

About ADIG ADI Global Distribution Inc. Common Stock

ADI Global Distribution Inc is a specialty distributor of professionally installed low-voltage products, including security and audio-visual (AV) solutions, serving commercial and residential markets through an omnichannel go-to-market platform. It sells to professional installers, dealers, and integrators. The company's product portfolio includes products from third-party suppliers across low-voltage categories, as well as products and services offered under its own brands. Its customer base includes independent contractors, systems integrators, and low-voltage specialists serving business, institutional, and residential end users.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: